Middle East Healthcare Company (4009.SR) — Cash flow
Operating, investing, and financing cash flow for Middle East Healthcare Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 302↓2.7% | 310↑72.1% | 180↑121.8% | 81↑322.3% | 19 | |
| Depreciation & Amortization | 246↑13.5% | 217↑14.2% | 190↑30.0% | 146↑3.2% | 141 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -152↓242.6% | 107↑126.2% | -408↓78.4% | -229↓88.6% | -121 | |
| Accounts Receivable | -76↓119.9% | 383↑154.9% | -698↓97.1% | -354↓976.5% | -33 | |
| Inventory | 2↓67.1% | 6↓92.9% | 85↑1431.4% | 6↑589.4% | -1 | |
| Accounts Payable | -36↑84.7% | -237↓278.8% | 133↑6.8% | 124↑307.1% | -60 | |
| Other Working Capital | -41↑9.1% | -46↓163.2% | 72↑1798.5% | -4↑84.4% | -27 | |
| Other Non-Cash Items | -40↓130.5% | 132↓42.1% | 229↑195.6% | 77↑108.1% | 37 | |
| Net Cash from Operating Activities | 355↓53.6% | 766↑300.9% | 191↑151.3% | 76↓0.8% | 77 | |
| Operating Cash Flow | 355↓53.6% | 766↑300.9% | 191↑151.3% | 76↓0.8% | 77 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -457↑2.9% | -471↓105.1% | -230↑8.0% | -250↑40.2% | -418 | |
| Capital Expenditure | -455↑5.0% | -479↓106.3% | -232↑6.9% | -250↑40.2% | -418 | |
| Acquisitions | 128 | 0.00 | 0.00↓100.0% | 0.13↑4.2% | 0.13 | |
| Purchases of Investments | -9↑82.4% | -51↓410.0% | -10 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00↓100.0% | 13↑647.0% | -2↓1959.0% | 0.13↑115.5% | -0.83 | |
| Net Cash from Investing Activities | -338↑33.5% | -509↓110.3% | -242↑3.0% | -249↑40.2% | -417 | |
| Financing Activities | ||||||
| Net Debt Issuance | 37↑184.6% | -44↓117.2% | 255↑4.1% | 245↓40.2% | 409 | |
| Long-Term Net Debt Issuance | -8↑80.9% | -44↓117.1% | 257↑4.8% | 245↓40.2% | 409 | |
| Short-Term Net Debt Issuance | 45 | 0.00↑100.0% | -2 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -46 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Dividends Paid | -46 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -31↑85.4% | -212↓21.1% | -175↓108.5% | -84↓46.5% | -57 | |
| Net Cash from Financing Activities | -40↑84.4% | -256↓421.2% | 80↓50.4% | 161↓54.3% | 352 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | -3↓146.6% | 7 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -26↓430.6% | 8↓72.7% | 29↑330.1% | -13↓211.7% | 11 | |
| Cash at Beginning of Period | 52↑17.7% | 44↑184.7% | 16↓44.5% | 28↑66.3% | 17 | |
| Cash at End of Period | 26↓49.7% | 52↑17.7% | 44↑184.7% | 16↓44.5% | 28 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -100↓134.8% | 287↑794.4% | -41↑76.2% | -174↑49.1% | -341 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.